| Cryoablation for the Treatment of Metastatic Cancer (NCT04150939) | M.D. Anderson Cancer Center | 2019-12-23 |
| Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer (NCT04068649) | Roswell Park Cancer Institute | 2019-11-18 |
| Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care (NCT03743649) | M.D. Anderson Cancer Center | 2019-07-17 |
| Financial Distress in Advanced Cancer Patients (NCT04053517) | M.D. Anderson Cancer Center | 2019-07-02 |
| Ride to Care - Quality of Life With Transportation for RT (NCT03849742) | University of California, San Francisco | 2019-05-15 |
| Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits (NCT03856060) | M.D. Anderson Cancer Center | 2019-03-30 |
| Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings (NCT04186884) | M.D. Anderson Cancer Center | 2019-03-26 |
| 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery (NCT05174026) | M.D. Anderson Cancer Center | 2018-11-30 |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085) | M.D. Anderson Cancer Center | 2018-11-14 |
| Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center (NCT03671226) | M.D. Anderson Cancer Center | 2018-09-28 |
| A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy (NCT03525873) | M.D. Anderson Cancer Center | 2018-08-02 |
| Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer (NCT03021486) | M.D. Anderson Cancer Center | 2017-06-05 |
| Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes (NCT02774291) | Albert Einstein College of Medicine | 2017-04-20 |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery (NCT02583269) | Wake Forest University Health Sciences | 2016-03-01 |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism (NCT02585713) | Academic and Community Cancer Research United | 2015-11-20 |
| Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery (NCT02540876) | University of Chicago | 2015-09-08 |
| Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer (NCT02491632) | M.D. Anderson Cancer Center | 2015-08-13 |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes (NCT02286687) | M.D. Anderson Cancer Center | 2014-12-22 |
| Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II) (NCT02152254) | M.D. Anderson Cancer Center | 2014-05-13 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease (NCT01552434) | M.D. Anderson Cancer Center | 2012-10-16 |
| Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases (NCT01592968) | M.D. Anderson Cancer Center | 2012-08-02 |
| Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer (NCT01664273) | Copenhagen University Hospital at Herlev | 2012-07-01 |
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers (NCT01624766) | M.D. Anderson Cancer Center | 2012-06-19 |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer (NCT01582191) | M.D. Anderson Cancer Center | 2012-05-14 |